- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07218991
- Ursprunglig rättegång
Bärbara ekolokaliseringshjälpmedel som använder parametriskt ljud
The objective of this study is to study a novel device designed to aid patients with impaired vision to safely navigate their environment. Subjects for this study will be individuals with normal vision, either with or without correction. The subjects will wear a device to simulate impaired vision and will be asked to walk a path with randomly placed obstacles during two trials. One of the trials will consist of the subject wearing the simulator alone. The other trial will consist of the subject wearing the simulator and the study device. The study device is designed to be worn by the study subject and will emit tones to indicate obstacles in the environment as the subject walks on the path with random obstacles. The tones will indicate that there is an obstacle in the individual's path and will increase in intensity as the subject moves closer to the object.Invest
Studieöversikt
Detaljerad beskrivning
The objective of this project is to study visually impaired individuals' ability to develop echolocation skills using simple, wearable, echolocation devices that will not be cost prohibitive to most Americans and that would allow for greater availability to the visually impaired community. These echolocation devices emit parametric sound, a directional beam of ultrasound waves that interact with sound waves and surrounding objects, through goggles, watches, lanyards or even walking canes. This allows the visually impaired individual to detect sound waves as they reflect off their surroundings and return to the patient's ears in unique patterns resembling their external environment. This device would enable individuals to create a raw mental image of their surroundings and any obstacles along their path.
The primary endpoint for this pilot study is to assess the feasibility of such echolocation devices as an adaptive low vision navigation aid on healthy subjects using low vision simulation goggles. Several metrics will be observed and recorded to measure how well echolocation technology addresses challenges associated with visual impairment and downstream factors. These metrics will include gait initiation, termination analysis via the Zeno-Walkway system, electromyography (EMG) of key muscles involved in gait termination, participant preference of echolocation wearable device modularity, and general survey questions.
The secondary study endpoint is to implement the use of echolocation technology among members of the blind or visually impaired population as a clinical aid and study the impact that this technology has on their quality of life and added downstream health implications longitudinally.
A final objective of this study is to seek feedback, not only on the use of any echolocation device to navigate but, to obtain feedback on subjects' experience with the specific study device, the Wearable Echolocation Device.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Texas
-
Galveston, Texas, Förenta staterna, 77555
- University of Texas Medical Branch
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Subject has provided informed consent in a manner approved by the Institutional Review Board (IRB) and is willing and able to comply with the trial procedures.
- Adults at least 18 years of age and no older than 100 years of age at the time of consent.
- Individuals in good health who can perform daily activities without assistance and can walk independently.
- Normal vision (with or without corrective lenses) if there is no uncorrectable visual impairment.
Exclusion Criteria:
- History of gait problems.
- Foot or leg impairments.
- Hearing impairment.
- Vertigo or other balance problems.
- Pregnant individuals.
- Any medical condition that, in the opinion of the investigator, would place the subject at increased risk for participation.
- Medications that may cause dizziness or weakness.
- Concurrent participation on another research study.
- Use of an investigational agent in the 30 days prior to signing informed consent.
- History of prior non-compliance.
- Presence or history of psychiatric condition (including anxiety, psychosis, drug, or alcohol addiction) that would, in the opinion of the investigator, make it difficult for the subject to comply with the study procedures or follow the investigators instructions.
- Non-English-speaking individuals.
- Individuals from special or vulnerable populations (i.e., adults unable to consent, minors, incarcerated individuals).
- Body weight greater than 700 pounds.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Inget ingripande: Group 1 - Wearing a Low-Vision Simulator without the Wearable Echolocation Device
The participant will be wearing a low-vision simulator and navigating a pathway randomly populated with obstacles. They will then perform the same trial, wearing the low vision simulator, navigating the same pathway with obstacles randomly rearranged; however, the participants will use the Wearable Echolocation Device to assist with navigation. |
|
|
Aktiv komparator: Group 2- Wearing a Low-Vision Simulator with the Wearable Echolocation Device
The participants will be wearing the low-vision simulator and the wearable echolocation Device for the first test to assist with navigating the pathway randomly populated with obstacles. The participant will then perform the same test, wearing the low-vision simulator without the Wearable Echolocation Device, navigating the same pathway with randomly rearranged obstacles. |
The device features many parametric speakers housed in a plastic case. The parametric speakers emit directional sound waves that return to the source with varying wavelengths depending on the distance of the surrounding objects. The device is designed to be worn by the subject either using a lanyard on the subject's neck, or on the subject's wrist. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Stride Length for Visually Impaired Individuals with Implementation of Echolocation Technology
Tidsram: Baseline (pre-training) and immediately post-training (same 30 minute session)
|
Stride length will be measured using the Zeno Walkway system, an electronic, pressure-sensitive mat connected to a PC that automates the measurement of spatial and temporal aspects of gait. The walkway's high-resolution sensors capture real-time data as participants walk across it. Each participant will walk on the instrumented mat for approximately 30 minutes, allowing for detailed analysis of stride length. Mean stride length (in meters) will be calculated from multiple trials to assess changes following implementation of echolocation technology. |
Baseline (pre-training) and immediately post-training (same 30 minute session)
|
|
Change in Cadence for Visually Impaired Individuals with Implementation of Echolocation Technology
Tidsram: Baseline (pre-training) and immediately post-training (same 30 minute session)
|
Cadence (steps per minute) will be assessed using the Zeno Walkway system, an electronic, pressure-sensitive mat that captures real-time gait data. Participants will walk across the instrumented walkway for approximately 30 minutes. The system will automatically record and calculate the average number of steps per minute to evaluate changes in cadence following implementation of echolocation technology. |
Baseline (pre-training) and immediately post-training (same 30 minute session)
|
|
Change in Walking Velocity for Visually Impaired Individuals with Implementation of Echolocation Technology
Tidsram: Baseline (pre-training) and immediately post-training (same 30 minute session)
|
Walking velocity will be measured using the Zeno Walkway system, an electronic, pressure-sensitive mat that captures spatial and temporal aspects of gait. Participants will walk across the walkway for approximately 30 minutes. The system will automatically calculate average walking velocity (in meters per second) based on distance and time. This outcome will be used to evaluate improvements in gait speed following implementation of echolocation technology. |
Baseline (pre-training) and immediately post-training (same 30 minute session)
|
|
Change in Body Mass Index (BMI) for Visually Impaired Individuals with Implementation of Echolocation Technology
Tidsram: Baseline (pre-training) and immediately post-training (same 30 minute session)
|
Body Mass Index (BMI) will be calculated using standard anthropometric measures of height and weight (weight in kilograms divided by height in meters squared). Measurements will be taken at each study visit to assess any change in BMI that may occur following implementation of echolocation technology. |
Baseline (pre-training) and immediately post-training (same 30 minute session)
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Participant-Reported Experience with Echolocation Device
Tidsram: Day 1
|
Participants will complete the "Wearable Echolocation Aids Using Parametric Sound: Post-Trials Survey" to evaluate their experience using the echolocation device during the study. |
Day 1
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Praveena M Gupta, PhD OD FAAO, University of Texas
Publikationer och användbara länkar
Allmänna publikationer
- Thaler L, Goodale MA. Echolocation in humans: an overview. Wiley Interdiscip Rev Cogn Sci. 2016 Nov;7(6):382-393. doi: 10.1002/wcs.1408. Epub 2016 Aug 19.
- GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021 Feb;9(2):e130-e143. doi: 10.1016/S2214-109X(20)30425-3. Epub 2020 Dec 1.
- Varadaraj V, Ehrlich JR, Swenor BK. Vision Impairment Has Implications for Aging and Health Outcomes, Beyond Ophthalmology. JAMA Netw Open. 2022 May 2;5(5):e2214610. doi: 10.1001/jamanetworkopen.2022.14610. No abstract available.
- Ong SR, Crowston JG, Loprinzi PD, Ramulu PY. Physical activity, visual impairment, and eye disease. Eye (Lond). 2018 Aug;32(8):1296-1303. doi: 10.1038/s41433-018-0081-8. Epub 2018 Apr 3.
- Swenor BK, Ehrlich JR. Ageing and vision loss: looking to the future. Lancet Glob Health. 2021 Apr;9(4):e385-e386. doi: 10.1016/S2214-109X(21)00031-0. Epub 2021 Feb 16. No abstract available.
- Sohl-Dickstein J, Teng S, Gaub BM, Rodgers CC, Li C, DeWeese MR, Harper NS. A Device for Human Ultrasonic Echolocation. IEEE Trans Biomed Eng. 2015 Jun;62(6):1526-1534. doi: 10.1109/TBME.2015.2393371. Epub 2015 Jan 16.
- Norman LJ, Dodsworth C, Foresteire D, Thaler L. Human click-based echolocation: Effects of blindness and age, and real-life implications in a 10-week training program. PLoS One. 2021 Jun 2;16(6):e0252330. doi: 10.1371/journal.pone.0252330. eCollection 2021.
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
- synskada
- blindhet
- nedsatt syn
- blind
- hjälpmedel
- synrehabilitering
- ljudvågor
- visuell hjälp
- sensorisk kompensation
- ekolokalisering
- parametriskt ljud
- parametrisk ljudteknik
- bärbar ekolokaliseringsenhet
- ekolokaliseringsteknik
- riktade ljudvågor
- ekolokaliseringshörlurar
- ekolokaliseringsförmåga
- ultraljudsvågor
- adaptivt navigeringshjälpmedel för svagsyn
- simuleringsglasögon för svagsyn
- navigationshjälp
- svagsynssimulator
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 24-0032
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .